Astrazeneca (AZN) EV to CFO (2009 - 2026)

Astrazeneca has reported EV to CFO for 18 years, with the latest figure at 100.77 in Q2 2026.

• On a quarterly basis, EV to CFO rose 63.13% year-over-year to 100.77 in Q2 2026; TTM through Jun 2026 was 21.07, a 34.9% increase from a year earlier, with the FY2025 full-year figure at 19.13, up 14.87% from the prior year.
• EV to CFO was 100.77 for Q2 2026 at Astrazeneca, up from 88.66 in the prior quarter.
• The five-year high for EV to CFO was 160.12 in Q2 2022, with the low at 24.9 in Q4 2023.
• Average EV to CFO over 5 years is 77.27, with a median of 68.9 recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: EV to CFO sank 77.59% in 2022, then soared 172.9% in 2024.
• Over 5 years, EV to CFO stood at 27.51 in 2022, then declined by 9.5% to 24.9 in 2023, then jumped by 172.9% to 67.95 in 2024, then jumped by 75.21% to 119.05 in 2025, then dropped by 15.36% to 100.77 in 2026.
• The last three EV to CFO figures came in at 100.77 (Q2 2026), 88.66 (Q1 2026), and 119.05 (Q4 2025), per Business Quant data.